JAN MALCOLM - 26 Jun 2025 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
26 Jun 2025
Transactions value $
$0
Form type
4
Filing time
28 Jul 2025, 06:10:06 UTC
Previous filing
26 Jul 2024
Next filing
10 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MALCOLM JAN Director C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING /s/ John S. Hess, Jr. under Power of Attorney 25 Jul 2025 0002028640

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $0 +630 $0.00 630 26 Jun 2025 Direct F1
transaction UTHR Common Stock Options Exercise $0 +590 +93.65% $0.00 1.22K 25 Jul 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Restricted Stock Unit Options Exercise $0 -630 -100% $0.00 0 26 Jun 2025 Common Stock 630 $0.00 Direct F1, F2, F3
transaction UTHR Restricted Stock Unit Options Exercise $0 -590 -100% $0.00 0 25 Jul 2025 Common Stock 590 $0.00 Direct F2, F3
transaction UTHR Restricted Stock Unit Award $0 +650 $0.00 650 24 Jul 2025 Common Stock 650 $0.00 Direct F3, F4, F5
transaction UTHR Stock Options Award $0 +1.83K $0.00 1.83K 24 Jul 2025 Common Stock 1.83K $306.41 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received upon vesting of restricted stock units on June 26, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock.
F2 Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock.
F3 Not applicable as restricted stock units do not have an expiration date.
F4 Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F5 Annual non-employee director award.